These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9027662)

  • 1. Urinary 1 beta-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy.
    Yamakawa R; Kimura A; Aoki K; Suzuki M; Mahara R; Tohma M
    J Gastroenterol; 1996 Dec; 31(6):917-8. PubMed ID: 9027662
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestasis of pregnancy: ursodeoxycholic acid therapy.
    Javitt NB
    J Hepatol; 1998 Nov; 29(5):827-8. PubMed ID: 9833923
    [No Abstract]   [Full Text] [Related]  

  • 3. Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
    Kadayifci A; Savas MC; Arslan S; Güllú IH
    J Clin Gastroenterol; 1997 Mar; 24(2):125-6. PubMed ID: 9077736
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of cholestasis and cholestatic disorders.
    Sanyal A
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C88-9. PubMed ID: 11293189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Kruizinga W
    Biochim Biophys Acta; 1987 Feb; 917(2):238-46. PubMed ID: 3801500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of cholestasis.
    Alvaro D
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():47-51. PubMed ID: 8899693
    [No Abstract]   [Full Text] [Related]  

  • 8. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury.
    Tanaka M; Nakura H; Tateishi T; Watanabe M; Nakaya S; Kumai T; Kobayashi S
    J Hepatol; 1999 Aug; 31(2):263-70. PubMed ID: 10453939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 11. How best to manage chronic cholestasis.
    Grattagliano I; Floreani A; Ubaldi E; Portincasa P
    J Fam Pract; 2018 Jul; 67(7):E9-E15. PubMed ID: 29989620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
    George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
    South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
    Matsuzaki Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].
    Barrio J; Castiella A; Lobo C; Indart A; López P; García-Bengoechea M; Cosme A; Arenas JI
    Rev Esp Enferm Dig; 1998 Jul; 90(7):523-6. PubMed ID: 9741209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby.
    Carey EJ; White P
    Evid Based Med; 2013 Dec; 18(6):e55. PubMed ID: 23635844
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
    Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
    An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
    Schmidt HH; Manns MP
    Am J Gastroenterol; 1996 Feb; 91(2):406-7. PubMed ID: 8607528
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Marschall HU
    Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.